Martine Chamuleau

DR., (Principal Investigator), PhD

1991 …2024

Research activity per year

Network

Tuna Mutis

Person: Academic

Inger Nijhof

Person: Academic

C.M. Eeltink

Person: Administrative

Canan Alhan

Person: Academic

Erik van Werkhoven

Person: Academic

Claudia Stege

Person: Academic

Laura Peferoen

Person: Academic

Julia Driessen

Person: Academic

Lianne Koens

Person: Academic

Mujde Durmaz

Person: Academic

Milan Kos

Person: Academic

Pieternella J. Lugtenburg

  • Erasmus MC University Medical Center Rotterdam
  • Erasmus Universiteit Rotterdam

External person

Marcel Nijland

  • Department of Hematology, United States
  • University of Groningen

External person

Avinash G. Dinmohamed

  • Erasmus University Medical Center
  • Netherlands Comprehensive Cancer Organisation (IKNL)
  • Vrije Universiteit Amsterdam
  • University of Amsterdam
  • Department of Research
  • Erasmus Universiteit Rotterdam
  • Department of Research and Development
  • Research and Development Department

External person

Hilma J. van der Horst

  • Vrije Universiteit Amsterdam
  • University of Amsterdam
  • Amsterdam UMC

External person

Marjolein W. M. van der Poel

  • Maastricht University

External person

H. Veelken

  • Leiden University Medical Centre

External person

Johannes S.P. Vermaat

  • Utrecht University
  • Department of Haematology
  • Leiden University

External person

Monique Minnema

  • University Medical Centre Utrecht, Utrecht, Netherlands
  • Utrecht University

External person

Franck Morschhauser

  • Centre Hospitalier Universitaire

External person

Gustaaf W van Imhoff

  • University Medical Center Groningen
  • University of Groningen

External person

Wendy B.C. Stevens

  • Radboud University Medical Center
  • University of the Witwatersrand

External person

Marije B Overdijk

  • Genmab B.V., Netherlands

External person

Rogier Mous

  • Utrecht University
  • Sanquin Blood Supply Foundation

External person

Michel van Gelder

  • Maastricht University

External person

Gilles Salles

  • BioRaN Team

External person

Lara H. Böhmer

  • Haga Ziekenhuis

External person

Jeanette K. Doorduijn

  • Erasmus MC Cancer Institute
  • Erasmus Universiteit Rotterdam

External person

Pim Mutsaers

  • Erasmus Universiteit Rotterdam
  • St Jansdal Hospital
  • Gold Coast University Hospital

External person

Tom van Meerten

  • University of Groningen

External person

Christine Hanoun

  • University of Duisburg-Essen

External person

Simone C Oostindie

  • Genmab B.V., Netherlands
  • Leiden University

External person

Maria Gomes da Silva

  • Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.

External person

Caroline Mandigers

  • Canisius Wilhelmina Hospital

External person

P.M. Kluin

  • University of Groningen

External person

Simone Pieplenbosch

  • Amsterdam UMC
  • Vrije Universiteit Amsterdam

External person

Hein P. J. Visser

  • Northwest Clinics

External person

Lara H Bohmer

  • Department of Internal Medicine, Netherlands

External person

Harald Holte

  • University of Oslo

External person

Rolf E. Brouwer

  • Diagnostic Center RDGG
  • Reinier de Graaff Gasthuis
  • Reinier de Graaf Groep
  • Dept. Hematol., (R.E.B., M.v.d.H.

External person

M.D. Levin

  • Albert Schweitzer Ziekenhuis
  • Dordrecht ASZ

External person

M. Brink

  • Comprehensive Cancer Organization the Netherlands (IKNL)

External person

Anne I J Arens

  • Radboud University Nijmegen

External person

Mels Hoogendoorn

  • Medical Centre Leeuwarden
  • MCL Academy

External person

Reinier A. P. Raymakers

  • Radboud University Nijmegen

External person

Martina Manni

  • University of Modena and Reggio Emilia

External person

Erik W. A. Marijt

  • Leiden University

External person

Katerina Bakunina

  • Erasmus Universiteit Rotterdam

External person

Clementine Sarkozy

  • Universite Claude Bernard Lyon 1

External person

Lina van der Straten

  • Albert Schweitzer Hospital, Dordrecht

External person

Miguel Alcoceba

  • Hospital Clínico Universitario de Salamanca

External person

J. Martijn Kerst

  • Netherlands Cancer Institute
  • St. Antonius Ziekenhuis
  • Antoni Van Leeuwenhoek Hospital

External person

Rob Fijnheer

  • Utrecht University

External person

Mirian Brink

  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands
  • Netherlands Comprehensive Cancer Organisation (IKNL)

External person

Johanna A. A. Bult

  • University of Groningen

External person

Guillaume Cartron

  • CHU Montpellier

External person

Julia Huijbregts

  • Gelre Ziekenhuizen

External person

M. van Gelder

  • Maastricht University Medical Center

External person

Luigi Marcheselli

  • University of Modena and Reggio Emilia

External person

Silvia Montoto

  • Queen Mary University of London

External person

Sandra Lockmer

  • Karolinska Institutet

External person

Wouter J. Plattel

  • University of Groningen

External person

Johan A. Dobber

  • University of Amsterdam

External person

R. L. Seefat

  • University of Amsterdam

External person

Kim Linton

  • The Christie NHS Foundation Trust

External person

M. jde Durmaz

  • Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht Netherlands

External person

Mark-David Levin

  • Albert Schweitzer Hospital, Dordrecht
  • Albert Schweitzer Ziekenhuis

External person

María Dolores Caballero Barrigón

  • Hospital Clínico Universitario de Salamanca

External person

Sabina Kersting

  • Haga Ziekenhuis

External person

A. M.P. Demandt

  • Maastricht University Medical Center

External person

Sara Alonso-Álvarez

  • Hospital Universitario Central de Asturias
  • Medical Department
  • Vrije Universiteit Amsterdam

External person

Emanuele Zucca

  • Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland

External person

Eduardus F.M. Posthuma

  • Reinier de Graaf Groep
  • Leiden University

External person

Clemens B. Caspar

  • Cantonal Hospital Baden
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

Sylvia Herter

  • Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland

External person

Tahamtan Ahmadi

  • Genmab
  • Genmab A/S

External person

Michael Gregor

  • Leiden University
  • Kantonsspital Luzern

External person

Hedwig M. Blommestein

  • Erasmus Universiteit Rotterdam
  • Netherlands Comprehensive Cancer Organisation (IKNL)

External person

Deepak Sampath

  • Genentech Incorporated

External person

Mark-David Levin

  • Albert Schweitzer Ziekenhuis

External person

Yan Xin

  • Gilead Sciences, Inc.

External person

Mehrdad Mobasher

  • Genentech Incorporated

External person

S. F. Barrington

  • King's College London

External person

Liping Fu

  • Amsterdam University Medical Centers
  • Amsterdam UMC
  • Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON)

External person

Joep M. Wllmink

  • University of Amsterdam

External person

Francien de Croon

  • Department of Internal Medicine, Rotterdam, Netherlands

External person

Yavuz M Bilgin

  • Department of Internal Medicine, Netherlands

External person

Ewa Paszkiewicz-Kozik

  • Maria Sklodowska-Curie Institute of Oncology

External person

Rob Brouwer

  • Reinier de Graaf Groep
  • Erasmus Universiteit Rotterdam

External person

Stefan Dirnhofer

  • University of Basel
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

Paul W. H. I. Parren

  • Leiden University
  • Genmab B.V., Netherlands
  • Lava Therapeutics

External person

Laura Magnano

  • Hospital Clinic de Barcelona

External person

Marjolein M. W. van der Poel

  • Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research Institute GROW, University of Maastricht, Maastricht, The Netherlands;

External person

Tamás Györke

  • Semmelweis University

External person

Nick Veltmaat

  • University of Groningen

External person

Marloes Cuijpers

  • Rijnstate Hospital

External person

G. Doreen te Raa

  • Ziekenhuis Gelderse Vallei

External person

Andre Goy

  • Rutgers - The State University of New Jersey, Newark

External person

R.J.W. van Kampen

  • Maastricht University Medical Center
  • Maastricht UMC

External person

Lucie Lépine

  • Sanofi-Aventis

External person

Yasmina I. M. Serroukh

  • Erasmus Universiteit Rotterdam

External person

Peter J.M. Valk

  • Erasmus MC
  • Erasmus Universiteit Rotterdam
  • Hôpital Citadelle

External person

Martin Kornacker

  • F. Hoffmann-La Roche AG

External person

S. Wittebol

  • Meander Medical Center

External person

Joost Kluiver

  • University of Groningen

External person

Lidwine W Tick

  • Maxima Medical Centre

External person

Carla Casulo

  • University of Rochester

External person

Christopher Chiu

  • Immunology Clinical Development Janssen Research and Development, LLC Spring House
  • Johnson & Johnson

External person

Jaap van Doesum

  • University of Groningen

External person

T. Bosch

  • National Institute of Public Health and the Environment
  • KU Leuven

External person

Laurens P. Kil

  • Genmab B.V., Netherlands

External person

Nick Veltmaat

  • University of Groningen, University Medical Center Groningen

External person

J. J. Cornelissen

  • University of Amsterdam

External person

Thorsten Zenz

  • University of Zurich

External person

O. S. Smeekes

  • Academic Medical Center
  • University of Amsterdam

External person

Margaret A Lindorfer

  • University of Virginia

External person

Martine S. Veldhuis

  • Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC (Location VU), Amsterdam, The Netherlands

External person

Wim E. Terpstra

  • Onze Lieve Vrouwe Gasthuis

External person

Julia E Huijbregts

  • Gelre Ziekenhuizen

External person

Catherine Thieblemont

  • Université Paris Cité

External person

Christian Klein

  • Roche Innovation Center Zurich

External person

Mark F. Durian

  • Elisabeth-Tweesteden Ziekenhuis

External person

Ilídia Moreira

  • Instituto Português de Oncologia do Porto Francisco Gentil E.P.E.

External person

Pieternella J Lugtenburg

  • Erasmus Universiteit Rotterdam

External person

R. S. van Rijn

  • Medical Centre Leeuwarden

External person

Emma E. Geerdes

  • cDepartment of Research and Development, Comprehensive Netherlands Cancer Organization, Utrecht, The Netherlands

External person

Aniko Sijs-Szabo

  • Leiden University

External person

Sabina S. Kersting

  • Haga Ziekenhuis

External person

Ran Ji

  • Sanofi

External person

Alessandro Re

  • Department of Obstetrics and Gynecology, Brescia, Italy

External person

Yorick Sandberg

  • Maasstad Hospital

External person

Martin Schipperus

  • Haga Ziekenhuis

External person

Carla Minoia

  • IRCCS Istituto tumori Giovanni Paolo II - Bari

External person

Mar Bellido

  • University of Groningen, University Medical Center Groningen
  • University of Groningen

External person

Gerjo A. Velders

  • Gelderland Valley Hospital

External person

Margriet Oosterveld

  • Canisius Wilhelmina Hospital

External person

Brian Elliott

  • Genmab A/S

External person

Gustaaf W van Imhoff

  • University of Groningen

External person

O. de Weerdt

  • St. Antonius Ziekenhuis

External person

D. F. E. Karssing

  • location Vrije Universiteit

External person

Pim G.N.J. Mutsaers

  • Erasmus Universiteit Rotterdam

External person

Urban Novak

  • Bern University Hospital ‘Inselspital’
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

Dena DeMarco

  • Genmab A/S

External person

Anna Sureda Balari

  • University of Barcelona

External person

Henriette Levenga

  • Groenehart Hospital

External person

Eric A. F. Marijt

  • Leiden University Medical Center - LUMC

External person

Gerwin Huls

  • University of Groningen

External person

Blanca Scheijen

  • Department of pathology, Nijmegen, Netherlands
  • Radboud University Nijmegen

External person

M. H. M. Raasveld

  • University of Amsterdam

External person

Herve Tilly

  • Centre Georges-François Leclerc

External person

Michael Roost Clausen

  • University of Southern Denmark

External person

Prashant V. Nannan Panday

  • University of Groningen

External person

Auke Beishuizen

  • Princess M?xima Center for Pedriatric Oncology
  • Dutch Childhood Oncology Group

External person

Rosa Rentenaar

  • Laboratory for Experimental Oncology and Radiobiology, 1105 AZ Amsterdam, Netherlands
  • Department of Medical Oncology, 1105 AZ Amsterdam, Netherlands

External person

J. A. Dobber

  • Amsterdam UMC

External person

Mar Bellido

  • University of Groningen

External person

Roberto S. Oliveri

  • Genmab A/S, Denmark

External person

Tommy Li

  • Genmab A/S

External person

Roberto Bolli

  • University of Louisville

External person

Jessica R. Plaça

  • University of Groningen, University Medical Center Groningen

External person

Diana Al-Sarayfi

  • University of Groningen, University Medical Center Groningen

External person

R. S. Boersma

  • Amphia Hospital

External person

Fatemeh Saberi Hosnijeh

  • Erasmus Universiteit Rotterdam
  • Utrecht University

External person

Anna Sureda

  • Institute Catala Oncologia

External person

Rolf Brouwer

  • Reinier de Graaf Groep

External person

Holger Hebart

  • Stauferklinikum

External person

F. Celik

  • Deventer Ziekenhuis

External person

M. Ron Schaafsma

  • Medisch Centrum Twente

External person

Erik W.A. Marijt

  • Leiden University Medical Center - LUMC
  • Leiden University

External person

S. Czibor

  • Semmelweis University

External person

L. Nieuwenhuizen

  • Maxima Medical Centre

External person

A. Roelof Jonkhoff

  • VU Medisch Centrum
  • Department of Haematology
  • Vrije Universiteit Amsterdam

External person

Jakoba J. Eertink

  • Vrije Universiteit Amsterdam

External person

Yngvild Nuvin Blaker

  • University of Oslo

External person

Jeroen H.N. van den Brakel

  • Genmab B.V., Netherlands

External person

J. Hendrik Veelken

  • Leiden University Medical Center - LUMC

External person

Won Seog Kim

  • Sungkyunkwan University

External person

Frank Stenner

  • University of Basel
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

Gerwin A. Huls

  • University of Groningen

External person

Jeannette Doorduijn

  • Erasmus MC Cancer Institute

External person

Kylie D. Mason

  • The Royal Melbourne Hospital

External person

Yujie Zhong

  • University of Groningen, University Medical Center Groningen

External person

Rinske S Boersma

  • Amphia Ziekenhuis

External person

Ellen Ingalla

  • Genentech Incorporated

External person

G. W. van Imhoff

  • University of Groningen

External person

Joost S. P. Vermaat

  • Leiden University Medical Centre

External person

Adeboye Henry Adewoye

  • Gilead Sciences, Inc.

External person

Cecilia Carpio

  • Vall d'Hebron Institute of Oncology

External person

Harry R Koene

  • St. Antonius Hospital

External person

M. C. Minnema

  • Center for Hemostasis

External person

Janneke W. de Boer

  • University of Groningen

External person

King H. Lam

  • Erasmus University Medical Center
  • Erasmus Universiteit Rotterdam

External person

Kristin Strumane

  • Genmab B.V., Netherlands

External person

Henk C. T. van Zaanen

  • Franciscus Gasthuis & Vlietland

External person

Lotte E. van der Wagen

  • Utrecht University

External person

Maria T. Kuipers

  • Amsterdam University Medical Centers

External person

Krimo Bouabdallah

  • French Society of Dermatology and Department of Dermatology, France

External person

Lara Böhmer

  • Haga Ziekenhuis

External person

Filipe Montes de Jesus

  • University of Groningen, University Medical Center Groningen

External person

L. Schouls

  • National Institute of Public Health and the Environment

External person

Klaas G. van der Hem

  • Zaans Medisch Centrum

External person

Attilio Guarini

  • IRCCS Istituto tumori Giovanni Paolo II - Bari

External person

Lyndah Dreiling

  • Gilead Sciences, Inc.

External person

Constantine S. Tam

  • Peter Maccallum Cancer Centre
  • University of Melbourne

External person

Martin Hutchings

  • University of Copenhagen

External person

Liane te Boome

  • Haaglanden Medisch Centrum

External person

M.J. Kersten

  • Academic Medical Center
  • University of Amsterdam

External person

Peter W.M. Johnson

  • VU Medisch Centrum

External person

E.F.M. Posthuma

  • Wageningen University & Research

External person

L. Ceriani

  • Università della Svizzera italiana
  • Swiss Group for Clinical Cancer Research

External person

Ward F. M. Posthuma

  • Reinier de Graaf Groep
  • Leiden University

External person

Paul A.F. Geerts

  • Deventer Ziekenhuis

External person

Michiel van den Brand

  • Radboud University Nijmegen
  • Rijnstate Hospital

External person

Rinske S. Boersma

  • Amphia Hospital

External person

Frank J Beurskens

  • Genmab B.V., Netherlands

External person

Leonie Strobbe

  • Gelre Ziekenhuizen

External person

Henrike E. Karim-Kos

  • Erasmus Universiteit Rotterdam
  • Department of Research
  • Netherlands Comprehensive Cancer Organisation (IKNL)

External person

F. de Boer

  • Leiden University

External person

Francien Huisman

  • University of Groningen

External person

Jan Paul de Boer

  • Netherlands Cancer Institute

External person

Lionel Karlin

  • Hospices civils de Lyon

External person

Diana Al-Sarayfi

  • University of Groningen

External person

Ronald P Taylor

  • University of Virginia

External person

Bas van Rees

  • Tjongerschans Hospital

External person

Carmelo Carlo-Stella

  • Humanitas University

External person

M. jde Durmaz

  • cDepartment of Research and Development, Comprehensive Netherlands Cancer Organization, Utrecht, The Netherlands
  • Amsterdam University Medical Centers

External person

Anne G. H. Niezink

  • University of Groningen

External person

Ellen van der Spek

  • Rijnstate Hospital

External person

Frederick W. Thielen

  • Erasmus Universiteit Rotterdam

External person

Chiara Rusconi

  • Division of Hematology, Milan, Italy

External person

Tjeerd J F Snijders

  • Medisch Spectrum Twente (MST)

External person

Roel J.W. van Kampen

  • Zuyderland MC
  • Zuyderland Medical Center

External person

N. G. Mikhaeel

  • King's College London

External person

Hendrik Veelken

  • Leiden University Medical Centre

External person

Jie Gao

  • Gilead Sciences, Inc.

External person

Lidwine W. Tick

  • Maxima Medical Centre
  • Maxima MC

External person

David Cunningham

  • University of California at Irvine

External person

Ka Lung Wu

  • ZNA Stuivenberg Department of Hematology

External person

Tetiana Skrypets

  • University of Modena and Reggio Emilia

External person

Frederik O. Meeuwes

  • Martini Ziekenhuis
  • University of Groningen, University Medical Center Groningen

External person

Andrew D. Zelenetz

  • Memorial Sloan Kettering Cancer Center

External person

Ludo M. Evers

  • Amsterdam UMC - University of Amsterdam

External person

Wim E. Terpstra

  • Onze Lieve Vrouwe Gasthuis
  • Onze Lieve Vrouwe Gasthuis (OLVG)

External person

L. C. De Wreede

  • Gemeinnützige GmbH
  • Leiden University Medical Center - LUMC
  • Leiden University Medical Centre
  • Leiden University

External person

Kuo-mei Chen

  • Genmab A/S

External person

Yavuz M. Bilgin

  • Department of Haematology, Goes, Netherlands
  • Admiraal de Ruijter Hospital Goes
  • Admiraal de Ruijter Hospital

External person

Anton W. Langerak

  • Department of Immunology, Rotterdam, Netherlands
  • Erasmus Universiteit Rotterdam

External person

Gerjo A Velders

  • Ziekenhuis Gelderse Vallei

External person

Geok Wee Tan

  • University of Groningen, University Medical Center Groningen

External person

Ada Azaryan

  • Genmab A/S

External person

Merve Eken

  • location Vrije Universiteit
  • Amsterdam UMC

External person

Edward N. van den Brink

  • Genmab B.V., Netherlands
  • Crucell NV

External person

Jan L. C. Loeffen

  • Princess Máxima Center for Pediatric Oncology

External person

Xaver U. Kahle

  • University of Groningen

External person

R. de Jong

  • Sanquin Blood Supply Foundation

External person

Sara Galimberti

  • University of Pisa

External person

Anne I. Arens

  • Radboud University Medical Center

External person

Raul Cordoba

  • Universidad Autónoma de Madrid

External person

Dolores Caballero

  • Hospital Clínico Universitario de Salamanca

External person

L. E.M. Oosten

  • Leiden University Medical Centre
  • Leiden University
  • University of Amsterdam

External person

Arjan Diepstra

  • University of Groningen

External person

Steven le Gouill

  • CHU de Nantes
  • Nantes Université

External person

E. F. R. de Vries

  • Sanquin Blood Supply Foundation

External person

Edith Szafer-Glusman

  • Genentech Incorporated

External person

Yvette van Norden

  • Erasmus Universiteit Rotterdam

External person

R. Q. Hintzen

  • Maasstad Ziekenhuis
  • Vrije Universiteit Amsterdam

External person

Mujde Durmaz

  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands

External person

Martijn M. Terpstra

  • University of Groningen, University Medical Center Groningen

External person

Friederike A.G. Meyer-Wentrup

  • Princess M?xima Center for Pedriatric Oncology
  • Dutch Childhood Oncology Group

External person

Mark F Durian

  • Elisabeth-Tweesteden Ziekenhuis

External person

Yujie Zhong

  • University of Groningen

External person

Tom van Meerten

  • Rijksuniversiteit Utrecht: Hematologie

External person

Marcel Nijland

  • University of Groningen

External person

Anke van de Berg

  • University of Groningen, University Medical Center Groningen

External person

Maya Schulpen

  • Princess Máxima Center for Pediatric Oncology

External person

J. M. N. Dubois

  • Amsterdam UMC

External person

Ellen C. Dompeling

  • Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands
  • Isala Clinics
  • Isala Ziekenhuis

External person

D Berry

  • University of Rochester

External person

Daniela Alves

  • University of Lisbon

External person

Juliette van den Noort

  • Genmab B.V., Netherlands

External person

C. Siemes

  • Deventer Ziekenhuis
  • Erasmus MC

External person

Anton W. Langerak

  • Erasmus Universiteit Rotterdam

External person

Janine Schuurman

  • Genmab B.V., Netherlands

External person

Yana Stepanishyna

  • University of Modena and Reggio Emilia
  • Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine

External person

Berris van Kessel

  • VU Medisch Centrum
  • Utrecht University
  • Vrije Universiteit Amsterdam
  • Genmab B.V., Netherlands

External person

Roelandt F. J. Schop

  • IJsselland Ziekenhuis

External person